Christopher Link
Concepts (400)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 47 | 2019 | 337 | 5.890 |
Why?
| | Amyloid beta-Peptides | 24 | 2021 | 241 | 4.170 |
Why?
| | Caenorhabditis elegans Proteins | 20 | 2019 | 210 | 2.980 |
Why?
| | Alzheimer Disease | 17 | 2023 | 622 | 1.860 |
Why?
| | Astrocytes | 3 | 2024 | 224 | 1.830 |
Why?
| | Peptide Fragments | 10 | 2021 | 699 | 1.540 |
Why?
| | RNA, Double-Stranded | 6 | 2023 | 56 | 1.350 |
Why?
| | Animals, Genetically Modified | 27 | 2018 | 250 | 1.270 |
Why?
| | Neurons | 10 | 2024 | 1642 | 1.210 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2024 | 276 | 1.110 |
Why?
| | DNA-Binding Proteins | 9 | 2023 | 1500 | 1.100 |
Why?
| | RNA-Binding Proteins | 4 | 2019 | 464 | 0.870 |
Why?
| | Coculture Techniques | 1 | 2024 | 246 | 0.800 |
Why?
| | Cell Differentiation | 2 | 2024 | 2050 | 0.790 |
Why?
| | RNA, Helminth | 5 | 2019 | 18 | 0.770 |
Why?
| | C9orf72 Protein | 5 | 2019 | 13 | 0.770 |
Why?
| | Heat-Shock Response | 2 | 2019 | 78 | 0.730 |
Why?
| | Amyotrophic Lateral Sclerosis | 7 | 2023 | 99 | 0.720 |
Why?
| | Animals | 65 | 2026 | 38109 | 0.650 |
Why?
| | Cell Nucleus | 3 | 2019 | 619 | 0.630 |
Why?
| | Gene Knockdown Techniques | 3 | 2021 | 336 | 0.620 |
Why?
| | Heat-Shock Proteins | 7 | 2010 | 138 | 0.610 |
Why?
| | Aging | 10 | 2023 | 1966 | 0.600 |
Why?
| | Green Fluorescent Proteins | 10 | 2019 | 405 | 0.590 |
Why?
| | Brain | 10 | 2026 | 2941 | 0.580 |
Why?
| | Disease Models, Animal | 18 | 2026 | 4569 | 0.580 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2019 | 132 | 0.560 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2018 | 42 | 0.540 |
Why?
| | Neurodegenerative Diseases | 4 | 2022 | 151 | 0.540 |
Why?
| | Endosomes | 1 | 2018 | 140 | 0.520 |
Why?
| | Transcriptome | 4 | 2021 | 1046 | 0.520 |
Why?
| | Trisomy | 1 | 2018 | 78 | 0.510 |
Why?
| | Longevity | 7 | 2021 | 173 | 0.510 |
Why?
| | Oxidative Stress | 12 | 2012 | 1339 | 0.490 |
Why?
| | Transcription, Genetic | 5 | 2019 | 1496 | 0.480 |
Why?
| | Down Syndrome | 2 | 2026 | 534 | 0.480 |
Why?
| | Proteins | 5 | 2021 | 1022 | 0.460 |
Why?
| | Receptor, Insulin | 3 | 2010 | 94 | 0.440 |
Why?
| | Genes, Helminth | 4 | 2018 | 30 | 0.420 |
Why?
| | Models, Animal | 2 | 2018 | 392 | 0.410 |
Why?
| | Paralysis | 3 | 2010 | 67 | 0.400 |
Why?
| | RNA Stability | 1 | 2014 | 119 | 0.400 |
Why?
| | Cytokines | 1 | 2021 | 2065 | 0.400 |
Why?
| | Gene Expression | 6 | 2016 | 1490 | 0.390 |
Why?
| | Immunity, Innate | 1 | 2019 | 846 | 0.390 |
Why?
| | Plant Extracts | 3 | 2010 | 187 | 0.380 |
Why?
| | Drosophila melanogaster | 4 | 2017 | 236 | 0.370 |
Why?
| | Cells, Cultured | 6 | 2024 | 4155 | 0.360 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1786 | 0.360 |
Why?
| | Molecular Chaperones | 2 | 2005 | 200 | 0.360 |
Why?
| | Gene Expression Regulation | 6 | 2016 | 2609 | 0.350 |
Why?
| | Luminescent Proteins | 5 | 2015 | 185 | 0.350 |
Why?
| | Autophagy | 2 | 2019 | 286 | 0.340 |
Why?
| | Transgenes | 6 | 2016 | 190 | 0.330 |
Why?
| | Peptides | 3 | 2019 | 998 | 0.320 |
Why?
| | Cell Death | 1 | 2012 | 383 | 0.320 |
Why?
| | Carrier Proteins | 2 | 2016 | 737 | 0.310 |
Why?
| | RNA Interference | 7 | 2018 | 476 | 0.290 |
Why?
| | Prealbumin | 2 | 2016 | 36 | 0.290 |
Why?
| | Sequence Analysis, RNA | 4 | 2021 | 442 | 0.280 |
Why?
| | Heat-Shock Proteins, Small | 1 | 2007 | 2 | 0.270 |
Why?
| | Stress, Physiological | 5 | 2021 | 453 | 0.270 |
Why?
| | Sleep | 2 | 2026 | 901 | 0.270 |
Why?
| | Alternative Splicing | 4 | 2018 | 249 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1217 | 0.260 |
Why?
| | Computational Biology | 2 | 2021 | 681 | 0.250 |
Why?
| | Hemolysin Proteins | 2 | 2018 | 36 | 0.250 |
Why?
| | Genes, Reporter | 3 | 2016 | 276 | 0.250 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2026 | 460 | 0.240 |
Why?
| | Hydrogen Sulfide | 3 | 2021 | 48 | 0.240 |
Why?
| | Synapses | 1 | 2010 | 439 | 0.240 |
Why?
| | Endotoxins | 2 | 2018 | 221 | 0.230 |
Why?
| | Humans | 36 | 2024 | 144957 | 0.230 |
Why?
| | Frontal Lobe | 2 | 2017 | 160 | 0.220 |
Why?
| | Endoplasmic Reticulum | 2 | 2019 | 266 | 0.220 |
Why?
| | Gene Deletion | 2 | 2018 | 389 | 0.220 |
Why?
| | Mutation | 10 | 2017 | 4099 | 0.220 |
Why?
| | Rats | 5 | 2019 | 5614 | 0.210 |
Why?
| | eIF-2 Kinase | 1 | 2024 | 29 | 0.210 |
Why?
| | Muscle Proteins | 1 | 2026 | 244 | 0.210 |
Why?
| | Mice, Inbred C57BL | 7 | 2026 | 5997 | 0.210 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2003 | 758 | 0.210 |
Why?
| | Electrodes | 1 | 2024 | 115 | 0.200 |
Why?
| | Nerve Tissue Proteins | 2 | 2024 | 592 | 0.200 |
Why?
| | Organisms, Genetically Modified | 1 | 2003 | 15 | 0.200 |
Why?
| | Primary Cell Culture | 2 | 2021 | 174 | 0.190 |
Why?
| | alpha-Crystallin B Chain | 1 | 2003 | 24 | 0.190 |
Why?
| | Mice, Knockout | 4 | 2024 | 3125 | 0.190 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 155 | 0.190 |
Why?
| | Brain Chemistry | 1 | 2003 | 116 | 0.190 |
Why?
| | Wakefulness | 1 | 2024 | 169 | 0.190 |
Why?
| | Transfection | 4 | 2012 | 940 | 0.180 |
Why?
| | Amino Acid Sequence | 5 | 2008 | 2157 | 0.180 |
Why?
| | Cell Line | 4 | 2019 | 2882 | 0.180 |
Why?
| | Protein Aggregation, Pathological | 2 | 2019 | 22 | 0.180 |
Why?
| | Sleep Wake Disorders | 1 | 2026 | 302 | 0.180 |
Why?
| | Sleep Deprivation | 1 | 2024 | 206 | 0.180 |
Why?
| | Microscopy, Fluorescence | 4 | 2010 | 418 | 0.180 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2002 | 96 | 0.180 |
Why?
| | Immunoblotting | 4 | 2019 | 300 | 0.170 |
Why?
| | Dipeptides | 2 | 2019 | 57 | 0.170 |
Why?
| | Bacterial Proteins | 3 | 2018 | 962 | 0.170 |
Why?
| | Complement C1q | 1 | 2021 | 33 | 0.170 |
Why?
| | Signal Transduction | 4 | 2016 | 5233 | 0.170 |
Why?
| | Mice | 15 | 2026 | 18365 | 0.170 |
Why?
| | Amino Acids, Sulfur | 1 | 2021 | 8 | 0.170 |
Why?
| | Interleukin-1alpha | 1 | 2021 | 57 | 0.170 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2021 | 13 | 0.170 |
Why?
| | Activating Transcription Factor 4 | 1 | 2021 | 22 | 0.170 |
Why?
| | Diet, High-Fat | 1 | 2022 | 261 | 0.170 |
Why?
| | Amyloidosis | 1 | 2001 | 44 | 0.160 |
Why?
| | DNA Repeat Expansion | 2 | 2017 | 12 | 0.160 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2019 | 117 | 0.160 |
Why?
| | Helminth Proteins | 1 | 2000 | 24 | 0.160 |
Why?
| | Staining and Labeling | 1 | 2001 | 151 | 0.160 |
Why?
| | Molecular Sequence Data | 5 | 2007 | 2931 | 0.160 |
Why?
| | Embryo, Mammalian | 2 | 2018 | 232 | 0.160 |
Why?
| | Hippocampus | 2 | 2018 | 967 | 0.150 |
Why?
| | RNA | 2 | 2018 | 940 | 0.150 |
Why?
| | Frontotemporal Lobar Degeneration | 2 | 2017 | 19 | 0.150 |
Why?
| | Mitochondria | 3 | 2016 | 984 | 0.150 |
Why?
| | RNA, Small Interfering | 2 | 2019 | 635 | 0.150 |
Why?
| | Ultracentrifugation | 2 | 2017 | 51 | 0.150 |
Why?
| | Viruses | 1 | 2021 | 165 | 0.150 |
Why?
| | Glutathione Reductase | 1 | 2019 | 25 | 0.150 |
Why?
| | Protein Aggregates | 2 | 2019 | 86 | 0.150 |
Why?
| | Frontotemporal Dementia | 2 | 2016 | 57 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 4 | 2015 | 675 | 0.140 |
Why?
| | Proteostasis | 1 | 2019 | 27 | 0.140 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 433 | 0.140 |
Why?
| | Acrylates | 1 | 2018 | 48 | 0.140 |
Why?
| | Morpholinos | 1 | 2018 | 29 | 0.140 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2018 | 27 | 0.140 |
Why?
| | Heterochromatin | 1 | 2019 | 67 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2000 | 381 | 0.140 |
Why?
| | Protein Structure, Secondary | 1 | 2019 | 369 | 0.140 |
Why?
| | Blotting, Western | 5 | 2017 | 1187 | 0.140 |
Why?
| | RNA Editing | 1 | 2018 | 26 | 0.140 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 86 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2022 | 367 | 0.130 |
Why?
| | Up-Regulation | 3 | 2009 | 852 | 0.130 |
Why?
| | Inclusion Bodies | 3 | 2016 | 27 | 0.130 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.130 |
Why?
| | Behavior, Animal | 3 | 2016 | 520 | 0.130 |
Why?
| | Phenotype | 4 | 2019 | 3164 | 0.130 |
Why?
| | Frailty | 1 | 2021 | 198 | 0.130 |
Why?
| | Cytoplasmic Granules | 1 | 2018 | 74 | 0.130 |
Why?
| | Autopsy | 1 | 2017 | 94 | 0.130 |
Why?
| | Glutathione | 1 | 2019 | 375 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 464 | 0.130 |
Why?
| | Saccharomyces cerevisiae | 2 | 2019 | 579 | 0.120 |
Why?
| | Animals, Newborn | 1 | 2019 | 902 | 0.120 |
Why?
| | Heterozygote | 1 | 2017 | 315 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2019 | 509 | 0.120 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 70 | 0.120 |
Why?
| | Cell Survival | 1 | 2019 | 1098 | 0.120 |
Why?
| | Phosphorylation | 2 | 2018 | 1733 | 0.120 |
Why?
| | Wound Healing | 1 | 2018 | 351 | 0.120 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2016 | 64 | 0.120 |
Why?
| | Intestines | 1 | 2018 | 358 | 0.110 |
Why?
| | Transcriptional Activation | 1 | 2017 | 383 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 826 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2016 | 292 | 0.110 |
Why?
| | Diet | 2 | 2021 | 1275 | 0.110 |
Why?
| | tau Proteins | 2 | 2006 | 115 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2007 | 245 | 0.110 |
Why?
| | Chromatin | 1 | 2018 | 561 | 0.100 |
Why?
| | RNA Polymerase II | 1 | 2017 | 351 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 477 | 0.100 |
Why?
| | Transcription Factors | 4 | 2011 | 1742 | 0.100 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 159 | 0.100 |
Why?
| | Neuroprotective Agents | 2 | 2012 | 143 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2009 | 428 | 0.100 |
Why?
| | Cerebellum | 1 | 2015 | 223 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2016 | 437 | 0.100 |
Why?
| | Glutathione Transferase | 2 | 2003 | 100 | 0.100 |
Why?
| | Microscopy, Confocal | 2 | 2012 | 321 | 0.090 |
Why?
| | Cricetulus | 2 | 2012 | 118 | 0.090 |
Why?
| | Shab Potassium Channels | 1 | 2012 | 20 | 0.090 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2012 | 44 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 771 | 0.090 |
Why?
| | Cricetinae | 2 | 2012 | 304 | 0.090 |
Why?
| | Neurites | 1 | 2012 | 50 | 0.090 |
Why?
| | Caloric Restriction | 2 | 2010 | 127 | 0.090 |
Why?
| | Electroencephalography | 2 | 2026 | 551 | 0.090 |
Why?
| | Male | 13 | 2026 | 72406 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 434 | 0.090 |
Why?
| | Sequence Analysis, Protein | 2 | 2008 | 33 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2012 | 1718 | 0.080 |
Why?
| | Promoter Regions, Genetic | 3 | 2010 | 1258 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 381 | 0.080 |
Why?
| | Protein Structure, Quaternary | 1 | 2010 | 116 | 0.080 |
Why?
| | Base Sequence | 2 | 2005 | 2191 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 851 | 0.080 |
Why?
| | Presenilin-1 | 2 | 2012 | 33 | 0.080 |
Why?
| | Fasting | 2 | 2022 | 277 | 0.080 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 64 | 0.080 |
Why?
| | Caffeine | 1 | 2010 | 74 | 0.080 |
Why?
| | Renin | 2 | 2007 | 34 | 0.080 |
Why?
| | Fertility | 1 | 2011 | 168 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2010 | 193 | 0.080 |
Why?
| | HSP70 Heat-Shock Proteins | 2 | 2017 | 76 | 0.080 |
Why?
| | NADPH Oxidases | 2 | 2007 | 124 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2017 | 3608 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2002 | 381 | 0.080 |
Why?
| | Prenylation | 1 | 2009 | 3 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 862 | 0.070 |
Why?
| | Neuropeptides | 1 | 2009 | 77 | 0.070 |
Why?
| | Renin-Angiotensin System | 2 | 2007 | 78 | 0.070 |
Why?
| | RNA, Messenger | 5 | 2018 | 2832 | 0.070 |
Why?
| | Antioxidants | 2 | 2021 | 549 | 0.070 |
Why?
| | Biotinylation | 1 | 2008 | 37 | 0.070 |
Why?
| | Endocytosis | 1 | 2009 | 168 | 0.070 |
Why?
| | Genitalia, Male | 1 | 1988 | 11 | 0.070 |
Why?
| | CHO Cells | 1 | 2008 | 171 | 0.070 |
Why?
| | Proteomics | 2 | 2005 | 1195 | 0.070 |
Why?
| | Movement | 1 | 2010 | 294 | 0.070 |
Why?
| | Antigens, Surface | 1 | 1988 | 157 | 0.070 |
Why?
| | Muscle, Skeletal | 2 | 2009 | 1796 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 1 | 2008 | 370 | 0.070 |
Why?
| | Survival Rate | 2 | 2010 | 2092 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 304 | 0.070 |
Why?
| | Oxidation-Reduction | 4 | 2019 | 1087 | 0.060 |
Why?
| | Ginkgolides | 1 | 2006 | 4 | 0.060 |
Why?
| | Spironolactone | 1 | 2007 | 39 | 0.060 |
Why?
| | Lysosomes | 1 | 2007 | 128 | 0.060 |
Why?
| | Hypertension, Renal | 1 | 2006 | 15 | 0.060 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2017 | 110 | 0.060 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2007 | 68 | 0.060 |
Why?
| | Cardiomegaly | 1 | 2007 | 174 | 0.060 |
Why?
| | Protein Biosynthesis | 2 | 2021 | 458 | 0.060 |
Why?
| | Isoflavones | 1 | 2005 | 26 | 0.060 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2005 | 11 | 0.060 |
Why?
| | Solubility | 1 | 2005 | 242 | 0.060 |
Why?
| | Phytotherapy | 1 | 2005 | 74 | 0.060 |
Why?
| | Dementia | 1 | 2009 | 304 | 0.050 |
Why?
| | Ventricular Remodeling | 1 | 2007 | 276 | 0.050 |
Why?
| | DNA | 2 | 2021 | 1464 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2012 | 2499 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2005 | 541 | 0.050 |
Why?
| | DNA Primers | 1 | 2005 | 512 | 0.050 |
Why?
| | Feeding Behavior | 1 | 2010 | 685 | 0.050 |
Why?
| | Sleep, REM | 1 | 2024 | 44 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 983 | 0.050 |
Why?
| | Protein Binding | 2 | 2002 | 2276 | 0.050 |
Why?
| | Genetic Vectors | 1 | 2005 | 337 | 0.050 |
Why?
| | Aged | 3 | 2017 | 25947 | 0.050 |
Why?
| | Genome | 2 | 2003 | 306 | 0.050 |
Why?
| | Models, Genetic | 1 | 2006 | 536 | 0.050 |
Why?
| | Neurofibrils | 1 | 2003 | 2 | 0.050 |
Why?
| | Plaque, Amyloid | 1 | 2003 | 19 | 0.050 |
Why?
| | Gliosis | 1 | 2023 | 29 | 0.050 |
Why?
| | Body Temperature | 1 | 2024 | 229 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2018 | 419 | 0.050 |
Why?
| | Onchocerca volvulus | 1 | 2003 | 1 | 0.050 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2023 | 87 | 0.050 |
Why?
| | Female | 6 | 2026 | 78376 | 0.050 |
Why?
| | Operon | 1 | 2002 | 69 | 0.050 |
Why?
| | Liver | 2 | 2021 | 1888 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3550 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1822 | 0.050 |
Why?
| | Hyperbaric Oxygenation | 1 | 2002 | 39 | 0.040 |
Why?
| | Prion Diseases | 1 | 2001 | 15 | 0.040 |
Why?
| | Multigene Family | 1 | 2002 | 204 | 0.040 |
Why?
| | Probability | 1 | 2002 | 312 | 0.040 |
Why?
| | Microscopy, Immunoelectron | 1 | 2001 | 43 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 427 | 0.040 |
Why?
| | Alkenes | 1 | 2001 | 13 | 0.040 |
Why?
| | Diet Therapy | 1 | 2021 | 37 | 0.040 |
Why?
| | Benzoates | 1 | 2001 | 50 | 0.040 |
Why?
| | Species Specificity | 1 | 2002 | 574 | 0.040 |
Why?
| | Motor Neurons | 1 | 2023 | 234 | 0.040 |
Why?
| | Down-Regulation | 1 | 2003 | 627 | 0.040 |
Why?
| | Hydrogen | 1 | 2021 | 73 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 863 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2026 | 2185 | 0.040 |
Why?
| | Spinal Cord | 1 | 2023 | 382 | 0.040 |
Why?
| | Methylamines | 1 | 2020 | 40 | 0.040 |
Why?
| | Nematoda | 1 | 1999 | 12 | 0.040 |
Why?
| | Muscles | 1 | 2021 | 333 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2021 | 188 | 0.040 |
Why?
| | Insulin | 1 | 2010 | 2507 | 0.040 |
Why?
| | Maleates | 1 | 2019 | 4 | 0.040 |
Why?
| | Nuclear Lamina | 1 | 2019 | 12 | 0.040 |
Why?
| | Sequestosome-1 Protein | 1 | 2019 | 15 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 330 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1371 | 0.040 |
Why?
| | Reproduction | 2 | 2011 | 207 | 0.040 |
Why?
| | Muscle Cells | 1 | 2019 | 42 | 0.040 |
Why?
| | alpha-Synuclein | 1 | 2019 | 46 | 0.040 |
Why?
| | Binding Sites | 1 | 2002 | 1331 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1167 | 0.040 |
Why?
| | Anxiety | 1 | 2026 | 1110 | 0.030 |
Why?
| | Dimerization | 1 | 1998 | 194 | 0.030 |
Why?
| | Proteolysis | 1 | 2019 | 173 | 0.030 |
Why?
| | Oxidants | 2 | 2012 | 103 | 0.030 |
Why?
| | Middle Aged | 2 | 2017 | 35928 | 0.030 |
Why?
| | Genetic Variation | 1 | 2002 | 984 | 0.030 |
Why?
| | Body Composition | 1 | 2021 | 706 | 0.030 |
Why?
| | Ribonucleoproteins | 1 | 2018 | 103 | 0.030 |
Why?
| | Antibodies | 1 | 2019 | 403 | 0.030 |
Why?
| | Genomics | 1 | 2002 | 836 | 0.030 |
Why?
| | Hydrogen Peroxide | 2 | 2012 | 336 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2007 | 157 | 0.030 |
Why?
| | Larva | 1 | 2017 | 242 | 0.030 |
Why?
| | Ubiquitinated Proteins | 1 | 2016 | 2 | 0.030 |
Why?
| | Transcriptional Elongation Factors | 1 | 2016 | 39 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2012 | 1311 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 60 | 0.030 |
Why?
| | Electron Transport | 1 | 2016 | 118 | 0.030 |
Why?
| | Nerve Degeneration | 1 | 2016 | 48 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2015 | 1 | 0.030 |
Why?
| | Mass Spectrometry | 2 | 2012 | 750 | 0.030 |
Why?
| | Ginkgo biloba | 2 | 2006 | 10 | 0.030 |
Why?
| | Atrophy | 1 | 2016 | 201 | 0.030 |
Why?
| | Drosophila Proteins | 1 | 2017 | 212 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 161 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 266 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2015 | 168 | 0.030 |
Why?
| | Polyadenylation | 1 | 2015 | 41 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2001 | 600 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2114 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 640 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 946 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 373 | 0.020 |
Why?
| | Clioquinol | 1 | 2012 | 1 | 0.020 |
Why?
| | Kidney | 1 | 2021 | 1496 | 0.020 |
Why?
| | Propanols | 1 | 2012 | 2 | 0.020 |
Why?
| | 2,2'-Dipyridyl | 1 | 2012 | 7 | 0.020 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2012 | 8 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 906 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 48 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2012 | 154 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2012 | 194 | 0.020 |
Why?
| | Apoptosis | 2 | 2012 | 2430 | 0.020 |
Why?
| | Cognition | 1 | 2020 | 1269 | 0.020 |
Why?
| | Disulfides | 1 | 2012 | 96 | 0.020 |
Why?
| | Gonads | 1 | 2011 | 23 | 0.020 |
Why?
| | Models, Molecular | 1 | 2016 | 1619 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2012 | 280 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2016 | 749 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2012 | 289 | 0.020 |
Why?
| | Alanine | 1 | 2012 | 171 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2012 | 276 | 0.020 |
Why?
| | Germ Cells | 1 | 2011 | 66 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2007 | 2540 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 210 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2003 | 8279 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2010 | 117 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3192 | 0.020 |
Why?
| | Blood Pressure | 2 | 2007 | 1769 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 202 | 0.020 |
Why?
| | Central Nervous System Depressants | 1 | 2010 | 83 | 0.020 |
Why?
| | Association Learning | 1 | 2010 | 71 | 0.020 |
Why?
| | Odorants | 1 | 2010 | 116 | 0.020 |
Why?
| | Ribosomes | 1 | 2010 | 191 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3082 | 0.020 |
Why?
| | Ubiquitin | 1 | 2009 | 86 | 0.020 |
Why?
| | Caenorhabditis | 1 | 1988 | 3 | 0.020 |
Why?
| | Microscopy, Interference | 1 | 1988 | 8 | 0.020 |
Why?
| | Sex Determination Analysis | 1 | 1988 | 9 | 0.020 |
Why?
| | Caspases | 1 | 2009 | 232 | 0.020 |
Why?
| | Serotonin | 1 | 2010 | 294 | 0.020 |
Why?
| | Hot Temperature | 1 | 2010 | 407 | 0.020 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2007 | 11 | 0.020 |
Why?
| | Paresis | 1 | 2006 | 30 | 0.020 |
Why?
| | Malondialdehyde | 1 | 2006 | 30 | 0.020 |
Why?
| | Valsartan | 1 | 2006 | 32 | 0.020 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2006 | 56 | 0.020 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 38 | 0.010 |
Why?
| | Chemotaxis | 1 | 2006 | 122 | 0.010 |
Why?
| | Tetrazoles | 1 | 2006 | 50 | 0.010 |
Why?
| | Neprilysin | 1 | 2006 | 47 | 0.010 |
Why?
| | Valine | 1 | 2006 | 80 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 128 | 0.010 |
Why?
| | Dynamins | 1 | 2005 | 36 | 0.010 |
Why?
| | Podocytes | 1 | 2006 | 80 | 0.010 |
Why?
| | Albuminuria | 1 | 2006 | 190 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 151 | 0.010 |
Why?
| | Motor Activity | 1 | 2010 | 722 | 0.010 |
Why?
| | Ethanol | 1 | 2010 | 627 | 0.010 |
Why?
| | Crystallins | 1 | 2005 | 61 | 0.010 |
Why?
| | Fibrosis | 1 | 2007 | 548 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3335 | 0.010 |
Why?
| | Naphthoquinones | 1 | 2003 | 19 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 392 | 0.010 |
Why?
| | Protein O-Methyltransferase | 1 | 2003 | 1 | 0.010 |
Why?
| | Drug Resistance | 1 | 2003 | 153 | 0.010 |
Why?
| | RNA, Spliced Leader | 1 | 2002 | 12 | 0.010 |
Why?
| | Trans-Splicing | 1 | 2002 | 12 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 556 | 0.010 |
Why?
| | Gene Silencing | 1 | 2003 | 205 | 0.010 |
Why?
| | Myocardium | 1 | 2007 | 939 | 0.010 |
Why?
| | Chronic Disease | 1 | 2007 | 1813 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 621 | 0.010 |
Why?
| | Pilot Projects | 1 | 2005 | 1890 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3869 | 0.010 |
Why?
| | Adult | 1 | 2015 | 40506 | 0.010 |
Why?
|
|
Link's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|